|
"kuo sc"的相关文件
显示项目 21-45 / 337 (共14页)
1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2022-05-25 |
A comprehensive evaluation of COVID-19 policies and outcomes in 50 countries and territories
|
Tsou, HH;Kuo, SC;Lin, YH;Hsiung, CA;Chiou, HY;Chen, WJ;Wu, SI;Sytwu, HK;Chen, PC;Wu, MH;Hsu, YT;Wu, HY;Lee, FJ;Shih, SM;Liu, DP;Chang, SC |
| 國家衛生研究院 |
2022-05-16 |
Discrimination of methicillin-resistant staphylococcus aureus by MALDI-TOF mass spectrometry with machine learning techniques in patients with staphylococcus aureus bacteremia
|
Kong, PH;Chiang, CH;Lin, TC;Kuo, SC;Li, CF;Hsiung, CA;Shiue, YL;Chiou, HY;Wu, LC;Tsou, HH |
| 國家衛生研究院 |
2021-11-25 |
In vitro and in vivo comparison of eravacycline- and tigecycline-based combination therapies for tigecycline-resistant Acinetobacter baumannii
|
Yin, T;Lai, JJ;Huang, WC;Kuo, SC;Chiang, TT;Yang, YS;the ACTION study group |
| 國家衛生研究院 |
2021-06-14 |
Antimicrobial resistance mechanisms and virulence of colistin-and carbapenem-resistant acinetobacter baumannii isolated from a teaching hospital in Taiwan
|
Ilsan, NA;Lee, YJ;Kuo, SC;Lee, IH;Huang, TW |
| 國家衛生研究院 |
2021-05-06 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan
|
Kuo, SC;Wang, YC;Tan, MC;Huang, WC;Shiau, YR;Wang, HY;Lai, JF;Huang, IW;Lauderdale, TL |
| 國家衛生研究院 |
2021-04-13 |
Multicentre study of risk factors for mortality in patients with acinetobacter bacteraemia receiving colistin treatment[Erratum:International Journal of Antimicrobial Agents. 2020 Jun;55(6):Article number 105956.]
|
Lee, YT;Sun, JR;Wang, YC;Chiu, CH;Kuo, SC;Chen, TL;Yang, YS;the, ASG |
| 國家衛生研究院 |
2021-04-05 |
The prediction values of carbapenemase detection methods and carbapenem susceptibility testing for clinical outcomes of patients with Acinetobacter bacteremia under carbapenem treatment
|
Lee, YT;Huang, TW;Liu, IF;Kuo, SC;Yang, YS;Lin, PY;Liu, CP;Liu, YM;Chen, TL;Wang, FD;Wang, YC |
| 國家衛生研究院 |
2021-02-27 |
Mobile resistomes of human pathogens in swine wastewater treatment plants
|
Kuo, HC;Liao, YC;Cheng, HW;Shih, SM;Chen, FJ;Kuo, SC |
| 國家衛生研究院 |
2021-01 |
Nonpolio enterovirus activity during the COVID-19 pandemic, Taiwan, 2020
|
Kuo, SC;Tsou, HH;Wu, HY;Hsu, YT;Lee, FJ;Shih, SM;Hsiung, CA;Chen, WJ |
| 國家衛生研究院 |
2021-01 |
Ser253Leu substitution in PmrB contributes to colistin resistance in clinical Acinetobacter nosocomialis
|
Yang, YS;Jeng, WY;Lee, YT;Hsu, CJ;Chou, YC;Kuo, SC;Chen, CC;Hsu, WJ;Chen, HY;Sun, JR |
| 中山醫學大學 |
2021 |
Comment on: Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries?
|
Yang, CC; Kuo, SC; Wei, JCC |
| 國家衛生研究院 |
2020-12-01 |
Susceptibility of Elizabethkingia spp. to commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods
|
Kuo, SC;Tan, MC;Huang, WC;Wu, HC;Chen, FJ;Liao, YC;Wang, HY;Shiau, YR;Lauderdale, TL |
| 國家衛生研究院 |
2020-11-26 |
Clinical and economic impact of intensive care unit-acquired bloodstream infections in Taiwan: A nationwide population-based retrospective cohort study
|
Wang, YC;Shih, SM;Chen, YT;Hsiung, CA;Kuo, SC |
| 國家衛生研究院 |
2020-10-31 |
Clinical and molecular characterization of Acinetobacter seifertii in Taiwan
|
Li, LH;Yang, YS;Sun, JR;Huang, TW;Huang, WC;Chen, FJ;Wang, YC;Kuo, TH;Kuo, SC;Chen, TL;Lee, YT;ACTION study group |
| 國家衛生研究院 |
2020-10-14 |
In vitro and in vivo activities of imipenem combined with BLI-489 against class D Beta-lactamase-producing Acinetobacter baumannii
|
Wang, YC;Huang, SW;Chiang, MH;Lee, IM;Kuo, SC;Yang, YS;Chiu, CH;Su, YS;Chen, TL;Wang, FD;Lee, YT |
| 國家衛生研究院 |
2020-10 |
Increased mcr-1 in pathogenic Escherichia coli from diseased swine, Taiwan
|
Liu, JY;Liao, TL;Huang, WC;Liu, YM;Wu, KM;Lauderdale, TL;Tsai, SF;Kuo, SC;Kuo, HC |
| 國家衛生研究院 |
2020-09-29 |
Influence of severity of infection on the effect of appropriate antimicrobial therapy for Acinetobacter baumannii bacteremic pneumonia
|
Kang, FY;How, CK;Wang, YC;Cheng, A;Yang, YS;Kuo, SC;Liu, CP;Liu, YM;Chen, TL;Lee, YT |
| 國家衛生研究院 |
2020-09 |
The effect of preventing subclinical transmission on the containment of COVID-19: Mathematical modeling and experience in Taiwan
|
Tsou, HH;Cheng, YC;Yuan, HY;Hsu, YT;Wu, HY;Lee, FJ;Hsiung, CA;Chen, WJ;Sytwu, HK;Wu, SI;Shih, SM;Wen, TH;Kuo, SC |
| 國家衛生研究院 |
2020-08-06 |
Emergence of mcr-1, mcr-3, and mcr-8 in clinical Klebsiella pneumoniae isolates in Taiwan
|
Chen, FJ;Lauderdale, TL;Huang, WC;Shiau, YR;Wang, HY;Kuo, SC |
| 國家衛生研究院 |
2020-08 |
Collateral benefit of COVID-19 control measures on influenza activity, Taiwan
|
Kuo, SC;Shih, SM;Chien, LH;Hsiung, CA |
| 國家衛生研究院 |
2020-04-23 |
Plasmid- and chromosome-located mcr-3 in mcr-1-positive Escherichia coli in Taiwan
|
Hsu, CY;Chen, FJ;Huang, WC;Liao, YC;Lauderdale, TL;Kuo, SC |
| 國家衛生研究院 |
2020-04-09 |
Multicenter study of the risk factors for mortality in patients with acinetobacter bacteremia receiving colistin treatment
|
Lee, YT;Sun, JR;Wang, YC;Chiu, CH;Kuo, SC;Chen, TL;Yang, YS |
| 國家衛生研究院 |
2020-03-31 |
Confronting tigecycline-resistant acinetobacter baumannii via Immunization against conserved resistance determinants
|
Chiang, MH;Yang, YS;Sun, JR;Wang, YC;Kuo, SC;Lee, YT;Chuang, YP;Chen, TL |
| 國家衛生研究院 |
2020-02-11 |
Bacterial membrane vesicles from Acinetobacter baumannii induced by ceftazidime are more virulent than those induced by imipenem
|
Chiu, CH;Lee, YT;Lin, YC;Kuo, SC;Yang, YS;Wang, YC;Liu, YH;Lin, JC;Chang, FY;Chen, TL |
| 國家衛生研究院 |
2020-01-07 |
Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016
|
Kuo, SC;Liu, CE;Lu, PL;Chen, YS;Lu, MC;Ko, WC;Hsueh, PR;Chuang, YC;Wang, FD;the SMART Asia-Pacific Group |
显示项目 21-45 / 337 (共14页)
1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
|
